Rituximab in the treatment of high responding inhibitors in severe haemophilia A. - Wikidata - awgldk - TriplyDB

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

http://www.wikidata.org/entity/Q34651588

about

Rituximab for treating inhibitors in people with inherited severe hemophilia Novel therapies for immune tolerance in haemophilia A.International workshop on immune tolerance induction: consensus recommendations.Inhibitor eradication with rituximab in haemophilia: where do we stand?Rituximab for treating inhibitors in people with inherited severe hemophilia.Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.

P2860

Q24186623-2FABB982-7078-4FDF-8F35-A73A036EE768 Q36661858-DBAA54DF-D7E2-4451-AFB5-E71E72A633C8 Q36861097-6AD0ED12-ACC6-4DA1-97E3-367933D2086B Q38195908-08D00F29-D43D-4471-92EF-7B932086C634 Q38661525-BCC8E6AD-EDA0-4FA6-8CA7-51BEFCE9038B Q45864954-3DCB462A-157A-473A-A91A-6FBFD528EB66 Q49866575-95AB3405-4546-4CFF-B41A-9CB4226E0601

P2860

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

http://www.wikidata.org/entity/Q34651588

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@ast

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@en

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@nl

type

label

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@ast

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@en

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@nl

prefLabel

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@ast

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@en

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

@nl

P1433

Q34651588-E3DAF224-8501-4866-803D-1D7347CB430C

P1476

Q34651588-4A5CD478-5200-4C3A-8CB9-D82787372200

P2093

Q34651588-23A82E9F-6767-429E-8464-BE066E6EA699

Q34651588-30381DBC-A3F7-450C-87E5-86CC534A5358

Q34651588-3662A364-F8CE-461F-8132-8D8206EFFF0B

Q34651588-5BEC2DAF-9FCB-485B-9751-37C63DF4072A

Q34651588-B3844D50-558C-45CF-A532-F958936C6DC0

P2860

Q34651588-100B5B9E-15E1-40C3-A242-2D6C83C60FBE

Q34651588-3E603B20-084F-4666-82DE-0A278CA8B454

Q34651588-9057ABE1-C82D-418F-A356-6EC2A58AEB8C

Q34651588-962ED29D-0DF6-4685-AB7F-2486D34A1A82

Q34651588-A2FCA69B-32B0-4F61-AB3B-92D3D77B2737

Q34651588-BAC33894-F052-4452-AF64-49D6BFAA220C

Q34651588-BE21B2FF-7FD8-4682-8F31-A37E59D9F7D2

Q34651588-C4740D3E-CDDC-41D0-B2E9-4690B8EE5503

Q34651588-D6A8EF5A-D03C-4371-BBD7-32ECDBDE0EB2

Q34651588-E0A9593F-22BC-4DC4-93D6-0F16B93AC5F4

P304

Q34651588-204D6DAB-73CF-4332-8999-1344BEF505E4

P31

Q34651588-707D7521-54CC-433C-B9DF-92BE730DD991

P356

Q34651588-28D94A16-9DE9-44EB-9C38-DDB433B1EF43

P433

Q34651588-3BF0FBA6-CDDB-447C-8773-4C915DC8553D

P478

Q34651588-3447BAB3-DD7A-4347-A7AE-6F4C5E099C07

P50

Q34651588-434FA1BF-D3F7-4A1A-B96D-71F3D6E68BD0

P577

Q34651588-6C8D926D-DCE3-437C-B0A6-1DB64D3AEE3A

P698

Q34651588-EC591C7C-EACF-4CDC-9DDD-E702C72F8BA3

P921

Q34651588-57AF6F6E-7BC5-4D82-AE86-6A4E3104575A

Q34651588-CA87997C-A585-4E74-9F43-14988FD2F5B8

P356

J.1365-2516.2006.01185.X

P1433

P1476

Rituximab in the treatment of high responding inhibitors in severe haemophilia A

@en

P2093

Aronis S

http://www.w3.org/2001/XMLSchema#string

Platokouki H

http://www.w3.org/2001/XMLSchema#string

Salavoura K

http://www.w3.org/2001/XMLSchema#string

Trimis G

http://www.w3.org/2001/XMLSchema#string

Tzortzatou-Stathopoulou F

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment.

Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.

Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review.

Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.

Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.

Systematic review of the management of patients with haemophilia A and inhibitors.

Rituximab for autoimmune haemophilia: a proposed treatment algorithm.

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

P304

95-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2516.2006.01185.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16409183

http://www.w3.org/2001/XMLSchema#string

P921